- Sort by Relevance
- Display 15 Products per page
Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: October 28, 2019 | Price: $4,000.00 – $8,000.00
The Global Market for Medical Devices, 10th edition, provides a comprehensive view of the medical device market and opportunity for medical device manufacturers, competitors, and investors. The report examines the companies in the market, the types of devices sold across the global market, and the country markets they are sold in. As part of its coverage, this report contains market sizing and forecasts for the world medical device market and the medical device markets of 50 countries, providing the following...Published: October 17, 2019 | Price: $5,000.00 – $10,000.00
Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the growing availability of HbA1c testing both at the professional level and at the self-testing level. Kalorama’s...Published: October 11, 2019 | Price: $5,000.00 – $10,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD...Published: September 27, 2019 | Price: $5,000.00 – $10,000.00
Issues facing the healthcare industry are challenging and complex, including staff reductions, increased service demands and funding cuts. It is not surprising then that many are looking to the advanced solutions that artificial intelligence (AI) can offer in this realm. Kalorama Information's report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and future market opportunity for AI in healthcare, already an almost two-billion-dollar market, with applications in workflow and population health, drug discovery and emerging applications in...Published: September 19, 2019 | Price: $5,000.00 – $10,000.00
By 2020, it is estimated that there will be 21 billion connected devices in the world. That will be five times as many as just four years ago. This fact affects healthcare as much as any industry. Internet of Things (IoT) in Healthcare tracks the trends around IoT in healthcare and makes specific market estimates and forecasts. The industry adoption of technology in healthcare is driven by an increase in government mandates, staffing shortages, improving clinical outcomes, and increasing pressures...Published: August 6, 2019 | Price: $3,000.00 – $6,000.00
With a demand in healthcare to lower unneeded emergency room visits and provide more options for patients, more and more customers will seek urgent care in the coming years. This report will provide marketers and business planners with the important data they need on this emerging channel of business. Kalorama has covered the urgent care trend with estimates of its impact on IVD and imaging since 2013. This Kalorama Information report, The Market for Urgent Care Centers, is a detailed...Published: August 2, 2019 | Price: $6,000.00 – $12,000.00
Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next-Generation Sequencing Markets provides an in-depth look at the sequencing market, including data for 2018-2023...Published: August 2, 2019 | Price: $8,000.00 – $16,000.00
Now in its 12th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. The 2,000-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market. 2000-Page Report Based on Vendor Reporting, Interviews, Vendor Activities Authored by Veteran IVD Analysts with Industry Knowledge 12 Detailed Market Chapters with 2019 Market Estimate Where is IVD Heading? – Market Segment...Published: July 23, 2019 | Price: $5,000.00 – $10,000.00
Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2014 to 2024, with 2019...Published: July 23, 2019 | Price: $4,500.00 – $9,000.00
Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts. Test Segments: Market Sizing and Forecasts There are several segments where testing at the molecular level has thrived, including the following: • HPV Testing • CT/NG Testing • Molecular Hepatitis Testing • HIV Testing...Published: July 19, 2019 | Price: $6,500.00
Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2019 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors,...Published: June 28, 2019 | Price: $2,000.00 – $4,000.00
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics...Published: June 6, 2019 | Price: $4,000.00 – $8,000.00
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...Published: May 30, 2019 | Price: $2,500.00 – $5,000.00
Saving sample volume, cutting down provider time, reducing costs, improving outcomes, these are goals of the healthcare system, and they are well suited to a test that can identify more than a single pathogen. It has been thought that numerous pathogens tested directly from clinical specimens could change up diagnostics, and many vendors have responded by producing syndromic multiplex panels with considerable capabilities. These single tests, designed to detect a number of organisms that might have caused a particular syndrome,...